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EXECUTIVE SUMMARY

The goal of this NORPLANT® assessment study IS to provide BKKBN, the Ministry of
Health, and various donor agencies (The World Bank and USAID) with detailed information on
the experience of NORPLANT® clients who had an insertion at least five or more years ago and
thus had the potential of using at least five or more years. The study interviewed 2,979 women
in 14 provinces. Major findings are presented below:

1.

The percent of the NORPLANT® insertion cohorts in the fifth, sixth, seventh, and
eighth years who have not had NORPLANT® removed.

All women interviewed for this study had NORPLANT® inserted 5 or more years before
the interview. For the entire sample, 8.2 percent had not yet had NORPLANT® removed at the
time of interview. The table below shows the very high continuation rate for each
NORPLANT® insertion cohort from 1987 through 1991. The table also illustrates that almost
all NORPLANT® acceptors (over 90 percent) continue through the fourth year. Then, between
the end of the fourth year and the end of the fifth year there is the beginning of a sharp drop in
use from 90 percent to 66 percent. This drop continues and accelerates from 66 percent to 10
percent use at the end of the sixth year.
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Life Table Cumulative Probabilities of Continuing with NORPLANT® to the End of the
Period
YEARS

PERCENT CONTINUING TO END OF PERIOD
NORPLANT® Insertion Cohorts
1987

1988

1989

1990

1991

All Cohorts

One

98.1

98.3

97.8

97.5

98.5

97.9

Two

95.0

96.3

95.4

96.0

95.9

95.8

Three

93.6

94.6

92.6

93.6

92.9

93.5

Four

90.3

91.5

90.0

89.8

87.3

90.1

Five

73.1

70.6

64.4

64.5

55.8

66.1

Six

17.5

14.9

13.2

4.6

Seven

10.0

7.5

2.4

Eight +

7.8

3.2

N=

360

590

2.

10.1
3.3
1.6

758

1073

197

2978

The social and demographic characteristics of NORPLANT® users who had a
removal compared with those who have not had a removal.

Compared with women who have already had NORPLANT® removed, those who have
not had it removed are more likely to be older in age, divorced or widowed, have had
NORPLANT® inserted recently in the 1990 or 1991 period, have more living children, have
accepted NORPLANT® for the purpose of stopping the next pregnancy rather than postponing,
and to be somewhat less likely to have been informed at time of insertion about the need for a
removal after five years of NORPLANT® use.
For the earliest three cohorts in the study -- 1987, 1988, and 1989 -- the percent of
NORPLANT® acceptors who fail to have a removal after a period of six to seven years remains
fairly constant at about 5 percent. Among the 1987, 1988, and 1989 insertion cohort, the five
percent consisted of 89 women. Nineteen of the 89 were age 45 or older and another 3 were
under age 45 but either divorced or widowed. If one assumes that these women are at relatively
low risk of pregnancy at least on the basis of age and marital status, that leaves 67 or 3.8 percent
of the 1987, 1988, and 1989 insertion cohorts at greater risk of pregnancy. These are women
who have used NORPLANT® for at least seven years, have not yet had a removal, are married,
iii

under the age of 45, and presumably sexually active. Clearly, these women constitute a high
priority target group for a NORPLANT® removal.

3.

The knowledge of NORPLANT® users about the need for a removal after five years
of use.

Approximately 95 percent of all NORPLANT® acceptors say they were informed at the
time of insertion that NORPLANT® had to be removed after five years. However, among those
who were not informed, 16 percent had not yet had NORPLANT® removed compared with 8
percent among those who had been informed. While this is not a particularly large absolute
difference, it does suggest the need for greater information to NORPLANT® clients about the
method and particularly about the need for removal after five years of use.
4.

The client's perspective on accessibility of NORPLANT® services and on insertion
and removal procedures; and any barriers the client experienced in seeking a
removal.

Almost half (46 percent) of clients who use government Health Centers for removal of
NORPLANT® list "easy to reach" as a reason, compared with only 31 percent of private facility
clients. Over a quarter of private facility users list "familiarity with
staff" as a reason for use compared with 16 percent who use Health Centers. Similarly, 21
percent of private facility users list "good service" as a reason for use compared with only 9
percent of Health Center users. Taken together, these data suggest that easy access to a service
facility, familiarity with the staff, and good quality services are important factors in a client's
decision to use a facility. Clients who attend either Health Centers or private facilities are
equally likely to leave the facility with rods still remaining in the arm (about 4 percent), to
experience pain during the removal (about 17 to 19 percent), and to experience serious bleeding
(about 3 to 4 percent).
Overall, about 91 percent of the women who asked for a removal received a removal
immediately. Among the 9 percent who did not receive immediate removal services, one fifth
said that the reason was a lack of provider staff to do the removal while another 19 percent said
they were persuaded not to have the removal.
Almost half (48 percent) of those who did not get an immediate removal had to wait less
than three days before receiving a removal. On the other hand, 27 percent of the women who
did not receive an immediate removal had to wait over a week before receiving a removal. Also,
about 45 percent of those who did not get an immediate removal had to ask 2 or more times
before they received a removal.
Among women who received a removal immediately upon request, only 26 percent
discontinued family planning use altogether, 46 percent switched to another family planning
method, and 31 percent accepted a second NORPLANT® implant. Among women who did not
iv

receive an immediate removal, 36 percent discontinued altogether, 50 percent switched to
another family planning method, and only 14 percent accepted a second NORPLANT® implant.
Helping women to obtain an immediate removal upon request is associated with less
discontinuation of family planning use, less switching to another family planning method, and
more acceptance of a second NORPLANT® implant.
It is noteworthy that over one-fourth of those who had not yet had a removal cited cost as
the major reason. Among other major reasons for not having a removal, 12 percent said they
were afraid of the removal procedure and almost 9 percent said they forgot the date.
5.

Use of Private Facilities for NORPLANT® Services

Nurse midwives and private practitioners play a significant role in the NORPLANT®
program. Overall 66 percent of all removals were done by nurse midwives and 33 percent by
doctors. Over a quarter (28 percent) of removals were done in private facilities, and 23 percent
were done during Safari camps.
6.

Backlog of Removal Cases

The findings on continuation rates from this study suggest that by the end of the sixth
year, most women have NORPLANT® removed. However, there is a fairly large discrepancy
between the total number of insertions reported in a given year and the total number of removals
reported for that cohort five or more years later. Earlier studies have noted that on the basis of
current service statistics, there may be a backlog of between 500,000 to 800,000 overdue
removal cases1. Yet if the continuation rates reported in this study are correct or nearly correct,
it is highly likely that the reason there appears to be a large backlog of removal cases is because
a very significant number of actual removals are never reported and thus clients continue to be
recorded in the service statistics system as NORPLANT® users.
There may be several reasons why removal cases have not been reported. First, until
very recently, nurse midwives were not permitted to do removals. Yet this study shows that 66
percent of removals were performed by nurse midwives. It seems highly unlike that a nurse
midwife who performed a NORPLANT® removal would subject herself to possible censure by
reporting the removal. Second, the 23 percent of removals done in Safari camps may also be
underreported. There is probably less attention to recording removals done under mass Safari
camp conditions than single removals done at a health facility. Third, there is also no apparent
incentive for private facilities to report the 28 percent of removals these facilities perform.
These three reasons alone probably lead to significant underreporting of removal cases and may
account for the large discrepancy between the total number of insertions recorded and the total
number of removals recorded.

1

Fisher, Andrew A., Soledad Diaz, Alejandro Herrin, and Joedo Prihartono, Report on
NORPLANT® Implants in Indonesia, The Population Council, May 1995, New York.
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7.

The reproductive intentions of current and past NORPLANT® users and the future
demand for NORPLANT® among women who used NORPLANT® in the past.

Early insertion cohorts are more likely to have a second NORPLANT® insertion and less
likely than more recent cohorts to switch to another family planning methods. For example, 32
percent of the 1987 insertion cohort elected to have a second NORPLANT® insertion after
removal of the first, but only 21 percent of the 1990 insertion cohort had a second
NORPLANT® inserted after the first. Conversely, 45 percent of the 1990 insertion cohort but
only 33 percent of the earlier 1987 insertion cohort switched to another method of family
planning after removal of NORPLANT®. These data suggest that there is a decline from earlier
insertion cohorts to more recent insertion cohorts for second NORPLANT® acceptance, and a
consistent increase for switching to another family planning method after NORPLANT®
removal. This pattern may indicate that women have more contraceptive options now than they
did several years ago and thus can choose methods other than NORPLANT® to meet their
contraceptive needs. On the other hand, it may indicate some dissatisfaction with
NORPLANT® compared with other methods. Whatever the case, the trend should be monitored
in the future in an effort to determine why more recent NORPLANT® insertion cohorts are less
likely to accept a second NORPLANT® implant and more likely to switch to another method.
Among all insertion cohorts, roughly one quarter discontinue family planning method use
after NORPLANT® removal. This percent is relatively constant and ranges from a high of 30
percent for the 1987 cohort to a low of 23 for the 1989 and 1991 cohorts. The reasons for
discontinuation may be many including menopause, desire for additional pregnancy, or
dissatisfaction with the use of contraception.

8.

Cost of NORPLANT® Removal

Like many countries, Indonesia is trying to create the conditions for a sustainable family
planning program that would spread service delivery costs between the client and the
government. The unit cost for NORPLANT® is higher than most other contraceptive methods.
In addition, there are service delivery costs associated with NORPLANT® that are not
associated with other methods.
Overall, 75 percent of the women who had a removal were charged a removal fee. By
region, there were major differences. Almost 86 percent of those who had NORPLANT®
removed in Java\Bali were charged a fee compared to 61 percent in OI-1 and 47 percent in OI-2.

For many women, this fee for removal must have come as a surprise. Among all women
who had a removal, 68 percent said that they had not been informed about a removal fee at the
time of the NORPLANT® insertion. There is considerable regional variation. While 61 percent
in Java\Bali had not been informed about a removal fee, 81 percent in OI-1 and 82 percent in
OI-2 had not been informed.
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Among those women who paid a fee for removal, most (about 60 percent) paid less than
Rps. 10,000. The majority of women consider the removal fee "average" and overall, only about
15 percent considered the fee "expensive".
These data on cost suggest that women are willing to pay for removal services but they
also clearly indicate that there is a need to inform them before the NORPLANT® insertion that
such a fee will be charged, and to provide a means to help those who cannot pay the removal fee.
If fee for service is to become a part of the system for financing family planning services,
women need to know ahead of time what the cost will be for contraceptive services so that they
can make an informed choice that fits their own financial circumstances.
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I. INTRODUCTION

NORPLANT® contraceptive implants were first introduced in Indonesia in 1981 through
a series of coordinated acceptability studies. Based on the results from these clinical and field
studies, NORPLANT® was introduced into the national family planning program in 1987.
Since that year, the number of acceptors has increased dramatically in most provinces,
particularly in Java and areas of Sumatra. As of March 1995, BKKBN service statistics indicate
that the cumulative number of NORPLANT® acceptors exceeded 2.6 million.
A number of NORPLANT® assessment and evaluation reports have been completed
over the past 8 years and considerable information about the method and its acceptance in
Indonesia already exists (see list of references at end of this report). For example, the recently
completed NORPLANT® study (BKKBN, 1993) reveals that the continuation rate over a fouryear period was about 80 percent, but declined to 55 percent in West Sumatra and 33 percent in
West Java over a five-year period. The fall-off suggests that many acceptors are returning for
removal at or just before the five-year deadline, as they should. On the other hand, the data from
this study also reveals that approximately 15 percent of acceptors do not return for a removal
even after six years of use.
An earlier study carried out in urban areas by Yayasan Kusuma Buana (YKB) found that
more than 20 percent of NORPLANT® acceptors failed to visit a clinic for removal after fiveyears of use. The most frequent reason given for not obtaining a timely NORPLANT® removal
after five years of use was the difficulty of remembering the removal date.
NORPLANT® removal after five-years of use has been emphasized by top BKKBN
officials many times. After five years of use, the efficacy of the method declines and the risk of
pregnancy including ectopic pregnancy increases. In a consultant report of May 1995, the
number of NORPLANT® acceptors who would require a removal in 1995/96 was estimated at
approximately between 370,000 and 385,000. Because of the large number of removals required
each year in Indonesia, the BKKBN has developed a client tracking plan and has initiated an
accelerated program to train providers in removal techniques and increase the availability of
removal services for clients.
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1.

Study Problem Statement

The number of acceptors who need 5-year removal services is steadily increasing because
the number of insertions five years earlier steadily increased. However, there are no reliable
statistics on the actual number of NORPLANT® clients at five, six, seven or even longer who
have not had a removal. In short, the magnitude of the NORPLANT® removal problem (if
indeed it is a problem) is not known. Without an understanding of the magnitude of the problem
and the geographical distribution of the problem, it is difficult if not impossible to plan
adequately for training additional providers, purchasing and distributing equipment and supplies,
and directing attention to the areas where there is a significant backlog of cases requiring
removal. The NORPLANT® Removal Assessment Study reported here was designed to obtain
information from a representative sample of former NORPLANT® users on the extent to which
removals had been completed on time.
2.

Study objectives

The goal of the assessment study was to provide BKKBN, the Ministry of Health, and
various donor agencies with detailed information on the experience of NORPLANT® clients
who had an insertion five or more years before the study interview and thus had the potential of
using NORPLANT® for at least five years. The study was designed to obtain data on
continuation rates, facilities and providers used for insertions and removals, complications or
side effects experienced, barriers to removal experienced, and other information. The specific
objectives of the study are:
To determine:
1.

The percent of NORPLANT® insertion cohorts in the fifth, sixth, seventh, and eighth
years who have not had NORPLANT® removed;

2.

The social and demographic characteristics of NORPLANT® users who had a removal
compared with those who have not had a removal.

3.

The knowledge of NORPLANT® users about the need for a removal after five years of
use.

4.

The client's perspective on accessibility of NORPLANT® services and on insertion and
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removal procedures; and any barriers the client experienced in seeking a removal;
5.

The use of public and private sector services, the reasons for using one sector over
another, and the cost to the client of NORPLANT® removal in the public and private
sectors;

6.

The reproductive intentions of current and past NORPLANT® users and the future
demand for NORPLANT® among women who used NORPLANT® in the past.

While a number of NORPLANT® studies have been conducted in the past and
information exists to give at least partial answers to the many questions concerning
NORPLANT® use, there is clearly a need for a more detailed picture on the magnitude of the
NORPLANT® removal problem at the regional level.
3.

Significance of the study

This study is expected to provide guidance to BKKBN and the MOH in developing a
routine, on-going removal strategy that is capable of providing quality services to all clients who
desire a removal before the five year due date, or require a removal at the five year anniversary
date. In particular, the study is expected to provide information on the role of the private sector
in removals, and the experience of NORPLANT® clients during the post five year period.
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II.

INDONESIAN NORPLANT PROGRAM

1.

Indonesian National Family Planning Philosophy

The Indonesian National Family Planning Program, under the direction of the National
Family Planning Coordinating Board (BKKBN), has achieved international recognition for its
accomplishment both in slowing the country's rate of natural increase and in creating an
effective, nation-wide family planning structure. The BKKBN of Indonesia is now in its twenty
fifth year. There have been many changes during this period which have expanded services
throughout the country.
The quality of care offered by family planning programs has received considerable
attention in recent years. The concern has been reflected in an increasing number of reports
about the quality of services provided BY family planning programs. A number of professional
articles have noted that issues of quality of care in reproductive health have been
underemphasized relative to issues of achieving family planning client targets. Recently,
however, along with the expansion of the program, a number of initiatives are currently
underway in Indonesia to address the issue of quality and how it relates to family planning
service delivery. The impact of these initiatives is now being monitored.
The BKKBN has declared that the improvement of quality of family planning services is
its priority objective for the coming year, with plans to "ensure that a wide range of
contraceptive methods is provided to clients through high quality services." BKKBN has
developed strategies to improve the management of client support services. Among BKKBN's
efforts to improve the quality of the program is the implementation of a number of workshops
on total quality management for top and middle managers, using an industrial management
model called "Total quality circle" (Gugus Kendali Mutu). Other elements of BKKBN's effort
to improve program quality include an increase in the number of providers (particularly
midwives), improvement of the training curriculum, and a Steering Committee on Quality set up
by ministerial decree in 1994.
The Ministry of Health (DEPKES) is in the process of moving quickly ahead to define its
own strategy for quality improvement with the drafting of a National Integrated Total Quality
Improvement Strategy. DEPKES' objective is to integrate a comprehensive quality assurance
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program into the national health delivery system with the introduction of standards of care for all
medical procedures at public hospitals and community health centers nationwide. The BKKBN
and DEPKES will need to continue their dialogue on quality improvement efforts, particularly
the coordination of program responsibilities.
Outside the government system, many innovative quality of care experiments have been
tested by non-governmental organizations (NGOs) and private providers in different economic,
geographic, and cultural settings nationwide. Many of these pilot efforts by organizations such
as Perkumpulan Keluarga Berencana Indonesia (PKBI) and Yayasan Kusuma Buana (YKB)
have implemented interventions to improve quality of care and to demonstrate its impact.
Unfortunately many of the lessons learned have not been sufficiently disseminated and therefore
have limited impact on the national family planning infrastructure and its policy-makers.
2.

Role of NORPLANT® in the Indonesian Family Planning Program

There are at least two distinct stages in the development of the Indonesian family
planning program. The first stage occurred before 1992 and the second after 1992. The
differences between these two stages are discussed below.
a.

Contraceptive Services Before 1992

Indonesia is ideal for studying family planning because the program is well developed
and offers a choice of an exceptionally wide range of contraceptive methods. The methods of
contraception now available include: combined oral contraception (COC), intrauterine devices
(IUD), progestogen only and combined monthly injections, condoms, spermacides, male and
female sterilization, and NORPLANT®.
Health centers or clinics (PUSKESMAS) and sub-centers are under the jurisdiction of
health departments of regency and sudistrict governments. These clinics serve as referral
facilities for Village Contraceptive Delivery Centers (VCDC) and Posyandus (Integrated Health
Service Posts) in the case of medical complications of contraception. In addition, staff of these
facilities offer contraceptive information and services for oral pills, IUDs, condoms and
injectables at fixed times -- usually three mornings a week.
As is true in many developing countries, between 1970 and 1980, a new series of tactics
was developed to promote the use of contraception. Most of these tactics have since been
abandoned. Among them were incentives for providers, targets for IUD insertions, integrated
health/family planning teams, special military drives, and so on. Each tactic was designed to
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increase the number of family planning acceptors. In order to expand the reach of
contraceptive services, staff of PUSKESMAS (public health center) participated in mobile
family planning clinics called "family planning safaris" which offered services and handled
side-effects and medical complications.
During this time, new features were added to family planning service delivery. In addition
to the clinic approach, the field-worker approach was introduced. Then, following the shift
away from the IUD towards greater pill use, the program strategy was changed again to the
community based approach. In the 1980s, another approach was introduced. This was the
special family planning drive called "safari" which mobilized local efforts for an intense, short
period of time to promote family planning use, in particular the IUD and NORPLANT®. The
Safari program tended to increase rapidly the number of new acceptors in a geographic area but
sometimes at the expense of quality of care and client follow-up.
Indonesia has always been open to the introduction of new contraceptive methods. In
addition to NORPLANT®, injectables are now extensively used. Currently Indonesia is using
over 75 percent of the world's production of NORPLANT®, and is building a NORPLANT®
manufacturing plant. Although significant, the number of contraceptors using this method is
still proportionately small -- about 5 percent in 1994 according to the DHS study and now
estimated to be about 7 percent of family planning users. Other forms of implants are being
developed and produced in the Netherlands and are being tested by the Indonesia family
planning program. The contraceptive effect of NORPLANT® implants lasts about 5 years;
consequently, it is a contraceptive of great potential for the program, although it is still
expensive (around US$ 17 per dose plus the insertion and removal costs).
b.

Contraceptive Services After 1992

A high priority for the State Ministry for Population is the implementation of Act
Number 10/1992 which focusses on population, development, and the family. This Act which
was passed only in late 1992 is a breakthrough for the Indonesian family planning program.
This law states that a woman's right to pursue her reproductive objectives, choice of method,
and rightful access to family planning information and quality services is legally recognized and
protected by law. One of the most important features is that the law also includes the right of
protection of those involved in family planning services.
The BKKBN has strived for improved quality of services for many years. Over the last
five years, quality of services has been one of the five top priorities of the program. Much work
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was done to develop quality improvement policies, strategies, and procedures that are
consistent with Indonesian culture and standards, not only for clinical services but also for all
work done under the family planning program. This includes IEC activities, management, and
staffing. Policy-makers believe that improving the quality of care in clinics and other family
planning settings has always been important, especially to enhance services, attract and serve
more clients, and increase contraceptive prevalence.
In 1992 (December) a BKKBN national workshop on Quality of Care was held with
the objectives to review current quality of care activities and approaches that are on-going and
to determine what future activities are needed. In addition to general awareness-raising, the
workshop focused on Indonesian input for a Regional Quality of Care Seminar held in
Bandung, Indonesia in February 1993 sponsored by the Population Council. The Seminar was
a high point for the Indonesia Quality of Care movement. At the seminar, government
commitment to quality of care was outlined, the family planning target system was suspended
by the State Minister of Population and Chairman of BKKBN, and quality of care from the
perspective of managers, providers, and clients was discussed.
The National Family Planning Coordinating board has moved into a new phase of its
development. This phase is characterized primarily by an effort to mobilize more private
sector family planning providers and convince more acceptors to be self- reliant in their use of
family planning. The key concept is to move more and more acceptors towards paying for
family planning services on their own. The policy of KB Mandiri (which means self-reliance in
family planning) seeks to internalize within people the concept of self reliance in the use of
contraceptives and the small family norm. A multi-media "blue circle" campaign is aimed at
making family planning acceptors aware that private doctors and midwives offer family
planning services and encouraging acceptors who can pay to use the private sector for their
family planning needs. Another campaign has been the Gold-circle which seeks to give
acceptors a wide range of affordable contraceptives.
For the future, Indonesia's challenge is not only to maintain the momentum, but also to
institutionalize family planning practices in a changing society. To achieve these goals, the
BKKBN recognizes the need to focus on a long-term strategy to strengthen the delivery of
high quality services.
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III.

STUDY DESIGN

This study used both quantitative and qualitative approaches to the collection of data on
the use of NORPLANT®. Through the quantitative approach, 2,979 current and former
NORPLANT® users were interviewed. In-depth interviews from approximately 50 field
workers and 50 cadres or community volunteers were also conducted. This report only
examines the data from the quantitative survey of current and former NORPLANT® users. A
subsequent report will focus on the findings from the qualitative study. The following section
discusses sample design and selection procedures, the survey instruments, data collection
activities, a follow-up study to look at validity and reliability issues, and the limitations of the
study.
1.

Sample Selection

For the NORPLANT® Assessment Study, a sample of current and former
NORPLANT® users was selected from women who had an insertion between April 1, 1987 and
March 31, 1991. A stratified, multi-stage, probability sampling design was adopted to select:
1.
2.
3.
4.
5.

Provinces,
Districts within provinces,
Sub-districts within Districts,
Villages within Sub-districts,
Current and former NORPLANT® users from the list of users maintained by the
volunteers at the Sub-district level.

Various sources of information can be used to draw a sample of NORPLANT® users in
Indonesia. Unfortunately, the number of women who had implants inserted between April 1,
1987 and March 31, 1991 varies depending on the source of information used. For this study,
the following considerations were taken into account:
a.

Primary attention should be given to including within the sample women residing
in Provinces known to have a heavy concentration of NORPLANT® users.

b.

The set of data collection instruments used should be relatively short and simple
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to reduce non-sampling error, reduce the cost of data collection and processing,
and facilitate the rapid completion of a report.
The first stage of sampling involved the selection of provinces. A list of provinces with
the total number of NORPLANT® acceptors who had an insertion between April 1, 1987 and
March 31, 1991 was used. Data collection for this study took place in April 1996. The last
insertion cut off date of March 31, 1991 was used in order to obtain a sample of women who had
the opportunity of using NORPLANT® for at least five years at the time of interview.
After obtaining the list of all provinces with the number of NORPLANT® users, the next
step was to eliminate provinces which had a small number of NORPLANT® acceptors. Any
province with less than 1 percent of the total NORPLANT® acceptors was eliminated. By using
this elimination criteria, a total of 17 provinces remained in the sample frame. The 10 provinces
dropped from the sample frame accounted for only 5 percent of all NORPLANT® acceptors
during the period from April 1987 through March 1991. The 17 provinces selected have
approximately 95 percent of the NORPLANT® acceptors who had an insertion during this same
period. Out of the 17 provinces, a total of 14 provinces were selected by a systematic random
sample process with probability proportion to the size (PPS) or number of NORPLANT®
acceptors who received an implant during the 1987-1991 period.
The next step involved the selection of districts within provinces. In order to obtain adequate
sample sizes for making statistical inferences, the provinces were grouped into three regions -Java-Bali, Outer-Island 1 (OI-1), and Outer-Island II (OI-2). The selection of districts within each
region was done by a systematic random selection with PPS. Sampling frames were developed by
asking each province to supply the list of districts with the number of NORPLANT® acceptors who
had an insertion during the period April 1, 1987 - March 31, 1991. The sampling frame for the
selection of districts also excluded districts with less than one percent of the total implant acceptors
in the province. The number of districts selected was: 24 districts from Java-Bali, 14 districts from
OI-1, and 12 districts in OI-2.
The third stage of sample selection involved the selection of sub-districts. Each selected
district was requested to provide a list of sub-districts with the number of NORPLANT® acceptors
who had an insertion during the period April 1, 1987 - March 31, 1991. In addition to an exclusion
criteria of less than one percent of the total number of implant acceptors in the district, sub-districts
with less than 40 acceptors were excluded. The 40 acceptors number was used because the sample
plan called for the selection of at least 40 acceptors from each sub-district.
From each selected district, a total of 3 sub-districts were selected by a systematic random
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sample with the PPS procedure. Through this process, a total of 150 sub-districts --72 sub-districts
from Java-Bali, 42 sub-districts from OI-1, and 36 sub-districts from OI-2 -- were selected.
The fourth stage of the sampling involved the selection of villages within the selected subdistricts. Information needed for the construction of a sampling frame was collected from a number
of sources, such as health centers, field workers, and community volunteers who maintain records
on each family planning acceptor in their area. Since the volunteers are from the local community,
they usually know and have records on who is using which method and when each acceptor started
use.
A large percent of the NORPLANT® insertions during April 1, 1987- March 31, 1991 were
performed in mass Safari camps. Records were kept at the health center where the Safari camp was
held. To be certain that the list from which the samples were to be selected was accurate, the health
center's records and the field worker's records were reconciled with the records of the volunteers.
Data available from these sources were also verified through an independent follow-up study carried
out in two provinces, West Java and Lampung. Findings from this follow-up study are discussed
in a separate report.
While constructing the sampling frame to select villages, a village with less than 20 total
acceptors was combined with an adjacent village so that the total equalled at least 20 acceptors.
Again, a random sample with the PPS procedure was used to select two villages from each selected
sub-district.
From the list of acceptors maintained by the community volunteers, two sets of samples,
each consisting of 10 acceptors who had the implants inserted during the period April 1, 1987 March 31, 1991 were selected from one or more villages. The first set was used as an original
sample, while the second was used whenever a case on the first list could not be interviewed for one
reason or another. The last stage of sampling was done by selecting 10 acceptors through a
systematic random sample procedure.
Because a sufficient sample size was needed in each of the three major regions in order
to make valid inferences, it was necessary to oversample in the OI-2 region that had the smallest
proportion of NORPLANT® users relative to the total. As a result, in the study sample there is
a higher proportion of NORPLANT® users in the OI-2 region than the proportion this region
actually accounts for according to service statistics. Conversely, in the sample there is a lower
proportion of NORPLANT® users in the Java-Bali region than the proportion this region
actually accounts for according to service
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statistics. A sample weighting procedure was applied to adjust for these differences between the
proportion in the sample by region and the proportion in national service statistics by region. The
weights are applied whenever all three regions are combined to provide a national estimate. Table
1 below provides the weighting factors for each region. The total number in the weighted sample
is 2,986. The weighting procedure had very little effect in terms of changing the percents reported
for any given variable.
Table 1:

Regional Weights Derived From the Percent Distribution of NORPLANT®
Acceptors in the Sample and in National Service Statistics by Region

Region

a. Study Sample Percent
Distribution

b. National Service
Statistics Distribution

Java- Bali
OI-1
OII-2

48.3
28.2
23.5

64.0
28.2
7.8

Total Percent

100.0

100.0

Number of
cases

2979

1,071,426

2.

Weighting
factor
(b/a)
1.33
1.00
0.33

2,986

Questionnaires

There were two kinds of data collection instruments used for this study: 1) A structured,
five-page questionnaire administered to all the sample NORPLANT® acceptors who had their
implants inserted during April 1, 1987 - March 31, 1991; and 2) A standard guideline set of open
ended questions administered to fieldworkers and community volunteers. The first instrument was
used to generate quantitative data reported below, and the second was used to obtain qualitative
information discussed in a separate report.
The acceptor's questionnaire was divided into five sections and identified as 'Form A', 'Form
B', 'Form C', 'Form D', and 'Form E'. Form A contains basic questions on socio-demographic
characteristics and on the acceptors' experience with NORPLANT®.
Form B was designed to be used only with those respondents who had NORPLANT®
removed. This part of the questionnaire collects information on the time when the implants were
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removed, reason for removal, any difficulties the acceptor experienced, method used after removal,
and other similar questions including the cost of the removal.
Form C was only used for those respondents who had not had a removal at the time of
interview. Form C starts by asking the main reason for not removing the implants. This is
followed by a series of questions to determine the respondents reproductive intention, knowledge
of other, back-up contraception, intention to get the implants removed, and knowledge regarding
the payment for the implant removal.
Form D was administered only to women who said they became pregnant while using
NORPLANT®. These women were questioned on the outcome of the pregnancy.
Finally, Form E was administered to all the respondents regardless of their current use status.
In this questionnaire, the respondent's satisfaction with the implants, contact with fieldworker and
cadre, and opinion about other implants which are likely to come out in Indonesia were asked.
The qualitative questionnaire administered to field workers and volunteers attempted to
collect the following type of information:
#
#
#
#
#
#
#
#
#
#

number of eligible women covered by the fieldworker;
number of current implant users by year and month of insertion;
knowledge about NORPLANT® and other methods;
perceived risk factors after 5 years of NORPLANT® use;
experience and training received;
frequency of contact with clients;
knowledge on availability of providers in the community;
knowledge about BKKBN link and match system;
efforts to locate overdue NORPLANT® implant acceptors;
recommended back-up contraception for the overdue cases;

Both the quantitative and qualitative questionnaires went through several drafts before they
were finalized. The drafts were pre-tested and revised thoroughly. The pre-testing of the
questionnaires was conducted by the senior members of the study team. The revised questionnaires
were introduced during the supervisor's training. During this training, several changes were made
as per discussion during the class exercise and field practice. Both questionnaires became final only
at the end of the supervisor's training.
The principal investigator and all the six regional investigators actively participated in the
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development of the survey instruments. The Population Council provided technical assistance
during the development of the questionnaires and subsequently during the data analysis stage.
3.

Field Staff Training

A total of six regional investigators, 20 supervisors, and 126 interviewers worked together
with the principal investigators to carry out this study. Regional investigators were experienced
researchers from the University of Indonesia. All 20 supervisors were recruited from the provincial
universities and they were faculty members who had experience working in other research projects.
The interviewers were also recruited from provincial universities. They all knew the local dialect
of the area where they conducted interviews. The majority of interviewers consisted of the
university teachers, recent graduates of public health, medical science, and social science. There
was a mixture of male and female interviewers with the exception East Java and NTT where all
interviewers were male.
Two levels of training were conducted. The first was for the supervisors and the second was
for the interviewers. A 5-day supervisors' training was conducted in Jakarta during March 11-15,
1996. In this training, the following areas were covered: NORPLANT® characteristics,
communication, probing technique, sampling, data management, and data quality assurance. The
training utilized various techniques such as class room lecture, role play, discussion, and field
practice. The training was conducted by the principal investigator and six regional investigators
with assistance from the Population Council.
The second level of training was for interviewers and was conducted for 3 days. The
interviewers' training was conducted in fourteen different provinces by the respective supervisors
with the help of the regional investigator. The principal investigator for the study developed a
standard training curriculum and materials to use. The interviewers' training covered introduction
to NORPLANT® with specific information on its contraindications, side-effects, counselling,
follow-up, and insertion and removal procedures; objectives of the study; interviewing techniques,
such as probing, and selection of sample villages and respondents. In addition to these topics, each
training session emphasized how to ask questions and mark the questionnaires properly. In order
to develop the interviewer's skill and confidence, they were actively involved in role playing (acting
as respondent as well as interviewer) and actual field practice. All the interviewers' training sessions
were completed before the end of March 1996.
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4.

Data Collection

Field work for data collection was started soon after the completion of the interviewers'
training. Field work was carried out by 20 teams. Each
team was headed by one supervisor. On average, each supervisor had about 6 or 7 interviewers.
Each team had one regional investigator to report the field activities and discuss field problems. Six
regional investigators divided their areas of responsibility and made supervisory visits to field areas
while the data collection was underway. The field work was conducted during May 1996 and
completed within 25 days.
Interviewers were responsible to interview NORPLANT® acceptors who had insertions
during April 1, 1987 - March 31, 1991. Supervisors were assigned the following tasks while they
were in field:
a.
b.
c.
d.
e.
f.
g.
h.
i.

Preparation of a list of implants acceptors;
Selection of sample respondents;
Replacement of sample respondents for non-response;
Assignment of interviewer work schedules;
Editing and coding of completed questionnaires;
In-depth interviews of field workers and volunteers;
Ten percent random spot-checks of the sample;
Ten percent re-interview for selected questions on random basis;
Reporting and sending completed questionnaires to the headquarter;

All completed questionnaires were edited by the supervisors. It was recommended that they
edit the questionnaires in front of the interviewer on the same day of the interview. If any errors
were made or questions missed, the interviewer was asked to return to the respondent and complete
the questionnaire. A ten percent random spot-check of the interviewing process and a ten percent
re-interview of respondents was done. Supervisors kept the records of the spot-checks and reinterviews. The quality of the data as determined by the spot checks and re-interviews is discussed
in the following section.
5.

Data Quality
This section of the report deals with two aspects of data quality:
1.

The response rate and different reasons for non-response;
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2.

The procedure for selecting a second respondent when the first could not be
found.

A sample of 3000 women who had NORPLANT® inserted between April 1, 1987 and
March 31, 1991 was selected for interviews. Out of this sample, 491 or 16.4 percent could not be
interviewed for various reasons. Interviewers were instructed to make four visits to a respondent's
address in an effort to reduce the number of non-response cases.
Of the 491 non-response cases, 60 percent were visited four times, 20 percent three times, 5 percent
two times, and 15 percent one time.
Table 2 below shows the major reasons for non-response by region. The two most common
reasons in each region for a failure to conduct an interview were respondent not at home (5 percent
for the entire sample) and respondent moved from the area (5.8 percent for the entire sample).
Interviewers made 4 visits to women who were not at home. The addresses of about 2 percent of
the 3000 women in the sample could not be located, 0.3 percent refused an interview, and 0.5
percent had died. About 2.5 percent of the 3000 sample were not interviewed either because they
had NORPLANT® inserted outside the cohort period (April 1, 1987 - March 31, 1991), or they
were found to be incorrectly classified as a NORPLANT® user. The total (all reasons combined)
non-response rate was 14.4 percent for the Java region, 23.5 percent for OI-1, 11.9 percent for OI-2,
and 16.4 across all regions.
Table 2:

Percent Distribution of reasons for non-response by Region

Reason for non-response

Java

OI-1

OI-2

1.7
4.4
5.5
0.1
0.3
2.4

4.8
5.2
8.6
0.4
0.4
4.2

0.3
5.8
3.3
0.8
1.0
0.7

2.2
5.0
5.8
0.3
0.5
2.5

1440

840

720

3000

Total Number of non-response cases

208

197

86

491

Non-response rate

14.4

23.5

11.9

16.4

Address not found
Not at home
Moved
Refused Interview
Died
Not implant acceptor, or not in study
cohort
Expected sample

All
Regions
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Follow-up studies such as the one reported here often experience fairly high non-response
rates, particularly as the time between the event in question (in this case, the NORPLANT®
insertion) and the time of the interview increases. While an overall non-response rate of 16 percent
is not atypical, it does raise questions about the validity of the data. Some caution needs to be taken
in accepting with complete confidence the precise value of any given figure.
Whenever a non-response situation was encountered, a replacement sampling strategy
was adopted. At the village level, an initial sample of 10 was selected from the list of all
NORPLANT® users in the village. As noted earlier, a second sample of 10 was used to select
whenever it was necessary to select a replacement case. Although 3,000 questionnaires were
completed, 21 were lost in the mail, resulting in a final total of 2,979 completed questionnaires.
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IV.

NORPLANT® USERS IN INDONESIA

1. Characteristics of Study Respondents
Table 4 provides basic information on the 2,979 (2,986 weighted total) current and
former NORPLANT® users located in 14 provinces who were interviewed as part of this study.
For the entire sample, the mean age of the respondents at the time of NORPLANT® acceptance
was 28 years. By region, the mean age at time of acceptance in Java/Bali was 27, in OI-1 29
years, and in OI-2 28 years.
Variable 3 in Table 4 indicates that over half of the women in the sample had
NORPLANT® inserted during 1989 and 1990. Variable 4 shows the life table cumulative
probability of continuing with NORPLANT® to the end of a period year. For the purposes of
constructing the life table, the terminal event is the date of NORPLANT® removal. For women
still using NORPLANT® at the time of the interview, the case is censored at the time of
interview. In each region, continuation is very high. At the end of the fourth year of use,
overall, 90 percent of acceptors are still using NORPLANT® and the differences between
regions are very small. By the end of the fifth year approximately two thirds of the acceptors
continue to use NORPLANT® and then by the end of the sixth year most obtain a removal. By
the end of the sixth year continuing users drop to about 10 percent.
Variable 5 indicates that the average number of living children at the time of acceptance
was 3.0 for the entire sample and 2.7 in Java, 3.5 in OI-1 and 3.4 in OI-2. At the time of
interview, which occurred five or more years after the NORPLANT® insertion, 98 percent of
the entire sample were still married while about 2 percent were divorced or widowed (Variable
7). Overall, about 11 percent of the acceptors were urban residents, although this varied
somewhat by region with almost 15 percent urban in OI-1 but only 4 percent in OI-2 (Variable
8).
Slightly over half of the acceptors in each region had no education or incomplete primary
education (Variable 10). The husband of the NORPLANT® acceptors was somewhat better
educated. Only one third had no education or an incomplete primary education (Variable 11).
Overall, about half of the husbands work in agriculture or fishing (Variable 12) . Almost 70
percent of the NORPLANT® acceptors work at home and this percent varies only slightly by
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region (variable 13). About 44 percent of acceptors said that when they had NORPLANT®
inserted they wanted to postpone their next pregnancy, while about 56 percent said that at the
time of insertion they did not want additional children (Variables 14 and 15). The percent
who want to postpone or stop future pregnancies does not vary between regions. Finally,
about three fourths of the respondents in each region have ever used some method of family
planning other than NORPLANT® (Variable 16).
This brief profile indicates that at the time NORPLANT® was inserted, the acceptors in
the study were relatively young in their late 20s, and on average had between 2 to 3 children.
NORPLANT® continuation rates for all regions are very high and only begin to drop significantly
between the fifth and sixth years of use. About 90 percent live in rural areas, slightly over half
have very little or no education, and about three fourths spend most of their time working at
home. Also, slightly over half do not want any additional children and about three fourths have
ever used some method of family planning other than NORPLANT®.
Table 4:

Selected Characteristics of the Sample by Region
Variable

Region
Java/
Bali

OI-1

OI-2

Weighted
Total

1. Number in sample

1440

840

699

2986

2. Mean age at insertion

27.4

29.4

27.9

28.0

3. Year of NORPLANT® insertion:
1987
1988
1989
1990
1991

12.4
23.2
25.4
32.4
6.6

15.0
13.7
25.4
41.4
4.5

8.0
20.3
25.6
36.9
9.2

12.8
20.3
25.4
35.3
6.2
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Variable

Region
Java/
Bali

OI-1

OI-2

Weighted
Total

98.8
96.9
94.2
90.7
65.6
10.1

96.8
93.8
92.0
88.0
63.2
7.9

97.3
95.7
93.8
91.4
70.6
12.8

97.9
95.8
93.5
90.1
66.1
10.1

5. Mean Number of living children

2.7

3.5

3.4

3.0

6. Married at time of interview

98.4

98.5

97.6

98.4

7. Divorced or Widowed at time of interview

1.6

1.5

2.4

1.6

8. Urban Acceptors

9.4

14.5

4.4

10.5

9. Rural Acceptors

90.6

85.5

95.6

89.5

10. No education or incomplete primary

55.5

53.6

51.1

54.6

11. Husband's education --none or
incomplete primary

37.9

32.9

35.5

36.3

12. Major occupation of husband -- percent in
agriculture or fishing

45.1

52.1

65.8

48.7

13. Work at home

71.5

62.0

65.5

68.4

14. Wanted to postpone next pregnancy at
time of insertion

44.4

44.4

44.5

44.4

15. Wanted to stop next pregnancy at time of
insertion

55.6

55.6

55.5

55.6

16. Ever Used Other FP methods

72.8

78.6

73.7

74.5

4. Life Table Cumulative Probabilities of
Continuing with NORPLANT® at end of:
One year
Two years
Three years
Four years
Five years
Six years

2.

NORPLANT® Use
In the following analysis, the sample of NORPLANT® acceptors is examined in terms of
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a number of independent variables. The dependent variable for this analysis is "Current Status"
which consists of four mutually exclusive categories:
1) CONTINUING

These are continuing NORPLANT® users who have not had a
removal.

2) NONUSER

These are former NORPLANT® users who have had a removal
but are currently not using another method.

3) OTHER FP

These are former NORPLANT® users who have had a removal
and are currently using a family planning method other than
NORPLANT®.
4) 2nd NORPLANT These are former NORPLANT® users who have had the first implants
removed and are currently using a second NORPLANT® set.
All the women in this sample of NORPLANT® users had an insertion between 1987 to
1991, or at least five or more years before the study interview. Variable 1 in Table 5 shows that
approximately 8 percent of the total sample have not yet had a removal. Another 25 percent have
had a removal and are currently not using another family planning method, 41 percent have had a
removal and switched to another method, and 27 percent have had a removal and then had a second
set of NORPLANT® rods inserted.
Table 5:

Selected Variables on NORPLANT® Use by Current Family Planning Status
Variable

PERCENT: CURRENT FAMILY PLANNING USE
STATUS OF NORPLANT USERS
Continuing
User

NonUser

Other
FP
User

Second
NORP
LANT
User

Weighted
N=

1. Current FP Status

8.2

24.5

40.5

26.8

2985

2. Region*
Java/Bali
OI-1
OI-22

9.9
4.6
7.7

23.7
25.4
28.3

35.8
48.7
49.1

30.6
21.3
14.9

1439*
840*
699*
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Variable

PERCENT: CURRENT FAMILY PLANNING USE
STATUS OF NORPLANT USERS
Continuing
User

NonUser

Other
FP
User

Second
NORP
LANT
User

Weighted
N=

1. Current FP Status

8.2

24.5

40.5

26.8

2985

3. Insertion Place
Safari Camp
Other

7.8
10.1

24.6
24.2

42.0
33.9

25.6
31.8

2419
565

4. Year of Insertion
1987
1988
1989
1990
1991

5.5
5.4
4.7
9.2
31.7

29.5
23.6
23.4
24.3
22.8

33.3
39.4
41.2
45.1
29.6

31.8
31.5
30.7
21.4
15.9

381
605
759
1054
185

5. Motivation to Use at time of
insertion
Postpone
Stop

4.3
11.3

34.4
16.7

40.1
40.7

21.2
31.2

1324
1660

6. Informed of Need for
Removal After 5 Years
Yes
No

7.8
15.6

24.5
24.0

40.9
32.9

26.9
27.5

2831
134

6.8
12.4

19.3
39.6

49.7
13.4

24.1
34.5

2217
759

7. Ever Use Other FP Methods
Yes
No
* = Unweighted N

By region (variable 2), among NORPLANT® users in Java, approximately 10 percent have
not yet had a removal compared with about 5 and 8 percent respectively among users in OI-1 and
OI-2 regions. These figures of course include women in the 1991 insertion cohort, many of whom
have just entered their sixth year of use and if their experience is like earlier cohorts, will soon seek
a removal. Java acceptors were also more likely to accept a second set of NORPLANT® after the
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first were removed, while the women in the other two regions were more likely to use some other
method of contraception after the removal of NORPLANT®.
Among the entire sample, 81 percent of the women received NORPLANT® insertions at
a Safari camp. Variable 3 indicates that 42 percent of the women who received NORPLANT®
at a Safari camp switched to another method after NORPLANT® was removed compared with
34 percent among women who received a NORPLANT® insertion elsewhere, usually at a fixed
facility such as a health center or hospital. Also, only 26 percent of those women who received
NORPLANT® at a Safari camp compared with 32 percent who received NORPLANT®
elsewhere accepted a second set of implants after the first set was removed. The difference
between those who received NORPLANT® at a Safari camp and those who received the
implants elsewhere by their current family planning status is statistically significant by a Pearson
Chi Square test (p <.001 with 3 df).
Variable 4 in Table 2 shows the year of insertion by current family planning
status. Almost one third of the 1991 insertion cohort (32 percent) are still using NORPLANT®
and have not had a removal. This is not unexpected. Many of these women have just entered
the sixth year of use and if their experience is similar to earlier insertion cohorts, most will
probably have a removal by the end of the sixth year. The other cohorts, however, represent
women who have had the potential to use NORPLANT® for six or more years.
Several features of variable 4 are noteworthy. Ignoring for the moment acceptors from
the most recent 1991 insertion cohort, many of whom have just completed their fifth year and
will probably have a removal during the sixth year, it appears that earlier insertion cohorts are
more likely to have a second NORPLANT® insertion and less likely than more recent cohorts to
switch to another family planning methods. For example, 32 percent of the 1987 insertion
cohort elected to have a second NORPLANT® insertion after removal of the first, but only 21
percent of the 1990 insertion cohort had a second NORPLANT® inserted after the first.
Conversely, 45 percent of the 1990 insertion cohort but only 33 percent of the earlier 1987
insertion cohort switched to another method of family planning after removal of NORPLANT®.
These trends are shown graphically in Figure 1 below.
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NORPLANT® acceptors who fail to have a removal after a period of seven or more years
remains fairly constant at about 5 percent. Among the 1987, 1988, and 1989 insertion cohort,
the five percent consisted of 89 women. Nineteen of the 89 were age 45 or older and another 3
were under age 45 but either divorced or widowed. If one assumes that these women are at
relatively low risk of pregnancy at least on the basis of age and marital status, that leaves 67 or
3.8 percent of the 1987, 1988, and 1989 insertion cohorts at greater risk of pregnancy. These are
women who have used NORPLANT® for at least seven years, have not yet had a removal, are
married, under the age of 45, and presumably sexually active. Clearly, these women constitute a
high priority target group for a NORPLANT® removal.
At the time of insertion, among the entire sample, 44 percent of NORPLANT® users
said they wanted to postpone their next pregnancy while 56 percent wanted to stop having
additional pregnancies. Variable 5, in Table 5, motivation to use NORPLANT®, indicates that
among women who wanted to stop having additional pregnancies, only 17 percent discontinued
family planning method use after NORPLANT® removal compared with 34 percent who
discontinued method use among those who wanted to postpone the next pregnancy. Also, while
31 percent of stoppers accept a second NORPLANT® implant after a removal, only 21 percent
of women who want to postpone pregnancy accept a second NORPLANT® implant. These
findings are not unexpected since they correspond with the initial fertility intentions of
NORPLANT® users. The initial motivation for using NORPLANT® is associated with
subsequent family planning method use, whether a second NORPLANT® implant or another
method.
Approximately 95 percent of all NORPLANT® acceptors say they were informed at the time
of insertion that NORPLANT® had to be removed after five years. However, among those who
were not informed, 16 percent had not yet had NORPLANT® removed compared with 8 percent
among those who had been informed. While this is not a particularly large absolute difference, it
does suggest the need for greater information to NORPLANT® clients about the method and
particularly about the need for removal after five years of use.
Three fourths of the entire sample said that they had ever used a method of family planning
other than NORPLANT®. Variable 7 in Table 5 indicates that among those who have ever used
another family planning method, after removal of the first NORPLANT® implant, only 24 percent
accepted a second NORPLANT® implant while 50 percent accepted another method of family
planning. A reverse trend can be seen among those who have never used another method of family
planning -- 35 percent accept a second NORPLANT® implant after removal of the first, and only
24 percent accept other family planning methods. The difference between the two groups is
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statistically significant using a Pearson Chi Square test at p <.01 with 3 df. While the reasons for
this difference are not apparent from the survey data, one can speculate that former users of other
family planning methods are more aware of the choices available to them and in comparing these
choices against a second NORPLANT® insertion, they tend to accept another method rather than
a second NORPLANT® implant.
3.

NORPLANT® Not Yet Removed

Women were only included in the sample frame for this study if they had a
NORPLANT® insertion at least five or more years prior to the date of the interview. At the
time of the study interview, 92 percent of the respondents already had NORPLANT® removed
while 8 percent were continuing users. Among the 8 percent, the following were the main
reasons they gave for not yet having NORPLANT® removed:
8.9 percent -- forgot the date,
12.0 percent -- afraid of the removal process,
26.1 percent -- removal cost too expensive,
4.6 percent -- didn't know it should be removed,
0.1 percent -- feared another insertion would be needed,
0.5 percent -- removal facility difficult to reach,
2.3 percent -- didn't know a removal facility
45.3 percent -- other reasons.
It is noteworthy that over one-fourth of those who had not yet had a removal cited cost as
the major reason. Among other major reasons for not having a removal, 12 percent said they were
afraid of the removal procedure and almost 9 percent said they forgot the date.
Table 6 below compares women who have not yet had NORPLANT® removed against those
who have had it removed (the last column of the table). For those who have not yet had a removal,
the data is also presented by region. The totals for both those who have not had a removal and for
those who have had a removal are based on weighted numbers. The region specific data of course
is not weighted. Comparing the last two columns of Table 6, a profile of those who have not had
a removal emerges. Compared with women who have already had NORPLANT® removed, those
who have not had it removed are more likely:
#
#
#

To be older in age (Variable 2);
To be divorced or widowed (Variable 3);
To have had NORPLANT® inserted recently in the 1990 or 1991 period
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#
#
#

Table 6:

(Variable 4);
To have more living children (variable 5);
To have accepted NORPLANT® for the purpose of stopping the next pregnancy
rather than merely postponing (Variable 6);
To be somewhat less likely to have been informed at time of insertion about the
need for a removal after five years of NORPLANT® use (Variable 7).
Percentage Distribution of the respondents who had not yet had NORPLANT®
removed by Region compared against those who have had NORPLANT®
removed by selected characteristics
NORPLANT NOT REMOVED
Variable

NORPLANT
REMOVED

Java/Bali

OI-1

OI-2

Weighted
Total

Weighted
total

1. Number sample

142

39

54

246

2,739

2. Age group:
< 30 years
30 - 34 years
35 - 39 years
40 plus

18.3
26.8
25.4
29.6

7.7
12.8
23.1
56.4

9.3
37.0
31.5
22.2

15.9
24.8
25.2
34.1

19.5
28.8
27.9
23.8

3. At Interview:
Married
Divorced/Widowed

96.5
3.5

97.4
2.6

92.6
7.4

96.3
3.7

98.5
1.5

4. Insertion Year:
1987
1988
1989
1990
1991

7.7
14.8
10.6
42.3
24.6

15.4
7.7
28.2
25.6
23.1

1.9
11.1
25.9
42.6
18.5

8.5
13.4
14.5
39.6
24.0

13.2
20.9
26.4
34.9
4.9

5. Living children:
1
2
3
4+

14.8
33.8
24.6
26.7

0
10.3
30.8
59.0

2.7
27.5
25.2
44.8

11.8
29.3
25.5
33.4

14.8
31.5
22.8
30.9
Page 27

6. Motivation to use at time
of insertion:
Postpone
Stop

24.6
75.4

15.4
84.6

25.9
74.1

23.3
76.7

46.3
53.7

7. Informed about need for
removal after 5 years:
Yes
No

88.0
12.0

92.3
7.7

96.3
3.7

89.3
10.7

95.4
4.1

Respondents who had not yet had a removal were also asked a series of other questions
regarding their fertility intentions in the future and their desire for a removal. Table 7 presents
the data from these questions by region.
Variable 1 indicates that over three fourths of women who had not had a removal do not
want another child. There is only slight variation by region with those in OI-2 being more likely
to not want another child. When asked if they wanted to have NORPLANT® removed, over 90
percent in each region said yes (Variable 2), and over half said they would prefer to have a
midwife do the removal instead of a doctor (Variable 3).
Overall, about a fourth of the women said they were not willing to pay for a removal, 14
percent said they would partially pay while 61 percent said they would be willing to pay in full
(Variable 4). By region, there is significant variation in terms of willingness to pay for the
removal. While almost three fourths (73 percent) of those in the Java/Bali region said they would
be willing to pay in full, this was true for only a third in OI-2 and about a fifth in OI-1.
By region, between 40 to 50 percent of the women who had not yet had a removal said
that they were aware a back-up method should be used if NORPLANT® is not removed after five
years (Variable 5). The primary source of knowledge about backup methods comes from the
PLKB/Cadre and the nurse midwives. However, despite the fact that overall, 43 percent said they
knew about the need for back-up contraception, only 16 percent were using a back-up method
and fully 84 percent were not using any back-up method. The pill is the method most likely to
be used for back-up.
Taken together, the data in Table 7 suggest that despite a desire to have NORPLANT®
removed, the cost of removal is perceived as a barrier for about a quarter of the women who have
not yet had a removal. Also, it is clear that more women need to be informed about the need for
using a back-up method after five years of NORPLANT® use.
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Table 7:

Percent of the respondents who had not yet had the implants removed by future
reproductive intentions and other variables by Region

Variable

Java/Bali

OI-1

OI-2

Weighted
Total

1. Desire for another child:
Yes
No
Not sure

15.5
77.5
7.0

17.9
76.9
5.1

13.0
83.3
3.7

15.7
77.8
6.5

2. Want to remove the implants
immediately:
Yes
No

92.1
7.9

92.3
7.7

96.3
3.7

92.5
7.5

3. Preferred provider for the
removal:
Doctor
Midwife

32.6
67.4

44.7
55.3

40.7
59.3

35.2
64.8

4. Willing to pay for the
removal:
Yes, full
Yes, partial
No

72.6
8.1
19.3

20.5
35.9
43.6

33.3
27.8
38.9

61.0
14.2
24.8

5. Know about backup method:
Yes
No

41.5
58.5

51.3
48.7

40.7
59.3

43.0
57.0

6. Source of knowledge on
backup method:
PLKB/cadre
Midwife
Doctor
Other

48.3
31.7
3.3
16.7

55.0
25.0
5.0
15.0

40.9
27.4
9.1
22.7

49.1
30.1
4.0
16.8
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Variable

Java/Bali

OI-1

OI-2

Weighted
Total

7. Backup method in use at time
of interview:
Injectable
Pill
IUD
other
None

2.8
8.5
0.7
4.2
83.8

0
7.7
0
5.1
87.2

7.4
11.1
0
1.1
79.6

2.7
8.5
0.5
4.2
84.0

4.

NORPLANT® Removed

Table 8 displays findings related to the 92 percent of respondents who already had a removal
at the time they were interviewed. Three quarters of the women said they had a removal because
it was time for a removal (Variable 1). The differences by region are small. Problems with menses
or other health problems account for about 8 percent of the reasons for removal, while desire for
pregnancy or pregnant while using NORPLANT® (see section below) account for about 7 percent
of the reasons for a removal.
Table 8:

Respondents Experience with NORPLANT® Removal by Region
Variable

1. Main Reason NORPLANT®
Removed:
It's time for removal
Desire pregnancy
Pregnant
Age/Menopause
Menses problems
Other health reasons
Advice Husband/other
Other

Region
Java/Bali

OI-1

OI-2

Weighted
Total
N=2740

75.7
6.4
0.7
0.3
4.5
3.2
1.3
7.8

79.2
5.0
1.4
0.2
3.1
5.6
0.5
5.0

75.5
5.7
1.9
0.5
4.2
5.4
0.6
6.2

76.7
5.9
1.0
0.3
4.1
4.1
1.0
6.8
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Variable

2. How Did Respondent Know It Was
Time for Removal (multiple responses
possible):
Remember myself
Reminded by family
Reminded by other user
Reminded by Kader
3. Get Removal Service Immediately:
Yes
No
4. IF NO TO #3, Main Reason
Removal Service not Provided
Immediately:
No provider staff
Persuaded not to remove
Have to pay removal fee
Other reasons
5. IF NO TO #3, Days had to Wait
Before Removal:
1 Day
2-3 Days
4-7 Days
8+ Days
6. IF NO TO #3, Number of Times
Had to Ask for Removal:
One
Two
Three +
7. Removal Time (minutes):
under 5
5-10
11-15
16-30
30+

Region
Java/Bali

OI-1

OI-2

Weighted
Total
N=2740

48.2
2.1
9.2
51.7

56.6
1.3
14.6
44.8

63.4
6.4
12.8
38.6

51.9
2.2
11.1
48.6

90.4
9.6

91.3
8.8

89.0
11.0

90.6
9.4

16.9
18.5
2.4
61.3

25.7
21.4
4.3
48.6

27.1
14.3
1.4
57.1

20.2
18.9
2.8
57.5

19.5
30.8
27.4
22.2

16.7
25.8
18.2
39.4

17.4
30.4
24.6
27.5

18.1
29.4
24.6
27.3

60.1
24.6
15.3

50.7
23.9
25.4

31.4
45.7
22.9

54.2
26.4
18.7

20.6
32.1
30.0
13.7
3.5

14.2
20.6
28.1
26.7
10.4

9.8
14.0
24.2
34.1
17.9

17.9
27.3
29.0
19.1
6.7
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Variable

Region
Java/Bali

OI-1

OI-2

Weighted
Total
N=2740

8. Who Did Removal:
Doctor
Nurse Midwife
Other

36.6
63.4
--

27.1
70.9
2.0

32.5
67.5
--

33.5
65.9
0.6

9. Removal at Safari Camp:

21.1

27.5

26.3

23.4

10. Removal Facility:
Health Center
Private facility
Other

62.9
29.1
8.1

51.6
29.7
18.7

71.4
13.7
14.9

60.2
28.1
11.7

Respondents were also asked how they knew it was time for a removal (Variable 2).
Multiple responses to this question were possible, two of which are noteworthy. First, slightly
over half of all respondents said that they remembered themselves that it was time for a removal.
Second, the village level Kader also were listed by respondents as an important source that
reminded them it was time for removal. In contrast, friends or other users were relatively
unimportant as a source of reminding clients. This data suggests that helping NORPLANT®
clients develop mechanisms to remind themselves of the removal date and emphasizing to Kader
the need to remind clients of the removal date may be effective ways to assure that clients do not
delay a removal after five years of use.
Overall, about 91 percent of the women who asked for a removal received a removal
immediately (Variable 3). By region, there is virtually no difference. Among the 9 percent who
did not receive immediate removal services, variable 4 of Table 8 indicates that overall, one fifth
said that the reason was a lack of provider staff to do the removal while another 19 percent said
they were persuaded not to have the removal. By region, women in OI-1 and OI-2 were more
likely to cite lack of a provider as a reason (26 and 27 respectively) than women in Java (17
percent). The cost of the removal was not a major factor and was mentioned by only about 3
percent of those who did not get an immediate removal.
Variable 5 of Table 8 indicates that almost half (48 percent) of those who did not get an
immediate removal had to wait less than three days. On the other hand, overall 27 percent of
these women had to wait over a week before receiving a removal, and fully 39 percent of the
women in OI-1 who did not receive an immediate removal had to wait over a week. Variable 6
shows that about 45 percent of those who did not get an immediate removal had to ask 2 or more
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times for the removal.
Variable 7 in Table 8 represents clients own perception of the length of time it took for
the removal. Overall, about 74 percent of those who had a removal said that the removal took
less than 15 minutes. By region, however, there are some major differences. In Java\Bali, 83
percent of the clients reported a removal in under 15 minutes compared with 63 percent of the
clients in OI-1 and 48 percent in OI-2. These differences may relate to the greater availability
of skilled providers in Java\Bali who have more extensive experience with removals. It may
also relate to fewer difficult removal cases in Java\Bali than in the Outer Islands.

Variables 8, 9, and 10 of Table 8 show that overall 66 percent of all removals were
done by nurse midwives, 23 percent were done during Safari camps, and 28 percent were
done in a private facility. Taken together, these findings may be part of the reason that there
tends to be a fairly large discrepancy between the total number of insertions reported in a
given year and the total number of removals reported for that cohort five years later. Earlier
studies have noted that on the basis of current service statistics, there may be a backlog of
between 500,000 to 800,000 overdue removal cases2. Yet if the percents noted in variables 78 of Table 8 are correct or nearly correct, it is highly likely that a very significant number of
actual removals are never reported and thus clients continue to be recorded in the service
statistics system as NORPLANT® users.

There may be several reasons why removal cases have not been reported. First, until
very recently, nurse midwives were not permitted to do removals. Yet this study shows that
66 percent of removals were performed by nurse midwives. It seems highly unlike that a nurse
midwife who performed a NORPLANT® removal would subject herself to possible censure
by reporting the removal. In short, in the past there has probably been a very strong incentive
for nurse midwives not to report any NORPLANT® removals. Second, the 23 percent of
removals done in Safari camps may also be underreported. There is probably less attention to
recording removals done under mass Safari camp conditions than single removals done at a
health facility. Third, there is also no apparent incentive for private facilities to report the 28
percent of removals these facilities perform. Indeed, past attempts to get private facilities to
report removals have not been successful.

2

Fisher, Andrew A., Soledad Diaz, Alejandro Herrin, and Joedo Prihartono, Report on
NORPLANT® Implants in Indonesia, The Population Council, May 1995, New York.
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These three reasons alone probably lead to significant underreporting of removal cases
and may account for the large discrepancy between the total number of insertions recorded
and the total number of removals recorded. While various findings from this study indicate
there is a need for more client information and attention to greater availability of removal
services as well as other aspects related to client use and removal of
NORPLANT®, overall by the end of the sixth year of use 90 percent of all clients have
received a removal and by the end of the seventh year the figure increases to over 95 percent.
In short, while some women may find difficulties in obtaining removal services and most
women use NORPLANT® beyond the recommended five year period, at least by the end of
the sixth year of use, this study did not find a large percent of women who had not had
NORPLANT® removed. The data from the study strongly suggest that private practitioners
and nurse midwives play a major role in removing NORPLANT®.
While the large percent of all NORPLANT® clients who ultimately manage to have
the rods removed by the end of the sixth year is a positive finding, it should also be noted that
a number of clients experience some difficulty in obtaining an immediate removal and this
difficulty seems to affect their future family planning status. Clients who are unable to obtain
removal services when they request these services can easily become discouraged and fail to
take necessary action after the five year use period. In this study, 91 percent of all
respondents were able to obtain removal services immediately upon request, and there are
virtually no differences by region (Variable 3 of Table 8). However, when the variable
"immediate removal" is examined in relation to current family planning status there are
statistically significant differences as can be seen below in Table 9.
Among women who received a removal immediately upon request, only 26 percent
discontinued family planning use altogether, 46 percent switched to another family planning
method, and 31 percent accepted a second NORPLANT® implant. Among women who did
not receive an immediate removal, 36 percent discontinued altogether, 50 percent switched to
another family planning method, and only 14 percent accepted a second NORPLANT®
implant. Helping women to obtain an immediate removal upon request is associated with less
discontinuation of family planning use, less switching to another family planning method, and
more acceptance of a second NORPLANT® implant.
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Table 9:

NORPLANT® Removal on Request by Current Family Planning Status

NORPLANT® Removed
Immediately on Request

FP Status After Removal
Discontinued FP
use

Switched to
Other FP
Method

Accepted 2nd
NORPLANT

Total

Yes (n = 2478)

25.7

43.5

30.8

100

No (n = 258)

35.9

49.7

14.4

100

Total (n = 2737)
26.7
Chi Square p <.0001 2 df.

46.2

29.2

100

While overall an immediate removal rate of NORPLANT® among 91 percent of the
entire sample is extremely good, the data discussed above indicate that there is room for
improvement among the 9 percent who did not get an immediate removal. By region, for
example, the lack of a provider to do a removal is far more likely to occur in OI-1 and OI-2
than in Java\Bali. Similarly, clients are more likely to have to wait a week or more in the Outer
Islands than in Java before they receive a removal. It seems likely that at least for some
women, the frustrations and difficulties in receiving immediate removal services may be a
factor in their discontinuing with family planning services and/or switching to other methods
of family planning.
5.

Use of Private Facilities for NORPLANT® Services

As noted above, private practitioners play a significant role in the NORPLANT®
program. Table 10 examines in greater detail the use of private facilities for NORPLANT®
services compared with government Health Center facilities. Respondents in the study were
asked to list the various reasons they had for using one type of facility over another. Multiple
responses were possible.
Variable 1 in Table 10 indicates that almost half (46 percent) of clients who use Health
Centers list "easy to reach" as a reason, compared with only 31 percent of private facility
clients. The inexpensive cost of service did not seem to make a difference in the use of a
facility. Inexpensive cost was noted by 18 percent of those who use a Health Center and 17
percent by those who use a private facility.
Two factors that appear to be important for clients who use private facilities are
"familiarity with staff" and "good service". Over a quarter of private facility users list
"familiarity with staff" as a reason for use compared with 16 percent who use Health Centers.
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Similarly, 21 percent of private facility users list "good service" as a reason for use compared
with only 9 percent of Health Center users. Taken together, these data suggest that easy
access to a service facility, familiarity with the staff, and good quality services are important
factors a client's decision to use a facility. Inexpensive services appear to be somewhat less
important.
Variable 2 in Table 10 reveals that there are virtually no differences between Health
Center clients and private facility clients with regard to the three removal problems listed.
Clients who attend either facility are equally likely to leave the facility with rods still remaining
in the arm (about 4 percent), to experience pain during the removal (about 17 to 19 percent),
and to experience serious bleeding (about 3 to 4 percent).
Table 10:

Place of Removal by Reasons for Using Facility and Problems with Removal.

PLACE OF REMOVAL
1. REASON THIS FACILITY USED
(Multiple responses possible)

Health center
(Weighted
N=1639)

Private Facility
(Weighted N=1083)

Easy to reach

45.5

30.8

Inexpensive/Cheap

18.1

16.7

Familiar with staff

15.8

26.0

9.2

21.0

Good service
2. PROBLEMS WITH NORPLANT
REMOVAL (Multiple responses possible)

PLACE OF REMOVAL
Health center

Private Facility

Rods remaining

3.5

3.5

Very painful

17.1

18.8

Serious bleeding

3.4

3.7

6.

Cost of NORPLANT® Removal

Like many countries, Indonesia is trying to create the conditions for a sustainable
family planning program that would spread service delivery costs between the client and the
government. The unit cost for NORPLANT® is higher than most other contraceptive
methods. In addition, there are service delivery costs associated with NORPLANT® that are
not associated with other methods.
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In this study, respondents were asked a number of questions regarding the cost of
NORPLANT® services. The responses to these questions are presented in Table 11.
Variable 1 in Table 11 shows that overall, 75 percent of the women who had a removal
were charged a removal fee. By region, there were major differences. Almost 86 percent of
those who had NORPLANT® removed in Java\Bali were charged a fee compared to 61
percent in OI-1 and 47 percent in OI-2. In short, there is considerable variation by region in
whether NORPLANT® clients are charged a fee for removal.
For many women, this fee for removal must have come as a surprise. Variable 2 in
Table 5 indicates that among all women who had a removal, 68 percent said that they had not
been informed about a removal fee at the time of the NORPLANT® insertion. Again, there is
considerable regional variation. While 61 percent in Java\Bali had not been informed about a
removal fee, 81 percent in OI-1 and 82 percent in OI-2 had not been informed.
Among those women who paid a fee for removal, most (about 60 percent) paid less
than Rps. 10,000. For reasons that are not apparent from the data, a higher percent of women
in the OI-2 region paid more than Rps. 15,000 for a removal than women in Java\Bali or OI-2.
However, as can be seen in Variable 4, the majority of women in all three regions seemed to
consider the removal fee "average" and overall, only about 15 percent considered the fee
"expensive".
Among those women who paid for a removal, there is a considerable difference in the
fee charged depending on whether the removal was done at a Government Health Center or a
private facility. For example, 71 percent of those who had the removal at a Health Center paid
Rps 10,000 or less compared with only 42 percent of those who had the removal done at a
private facility. Conversely, while only 8 percent of those who had a removal at a Health
Center paid Rps. 15,000 or more, fully 28 percent of those who had the removal at a private
facility paid Rps 15,000 or more.
These data on cost suggest that women are willing to pay for removal services and
they are willing to pay more at a private facility than at a Government facility, but the data also
clearly indicate that there is a need to inform women before the NORPLANT® insertion that a
removal fee will be charged. Among all women who had a removal, slightly over a quarter
were informed about a removal fee at the time of insertion. If fee for service is to become a
part of the system for financing family planning services, women need to know ahead of time
what the cost will be for contraceptive services so that they can make an informed choice that
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fits their own financial circumstances.
Table 11:

Cost of NORPLANT® Removal Services by Region

Variable

Region
Java/
Bali

OI-1

OI-2

Tot.

85.6
14.2
0.2

60.6
39.4
--

46.9
52.7
0.3

75.4
24.5
0.1

37.3
61.1
1.6

17.9
80.5
1.7

13.1
82.4
4.5

29.9
68.2
1.8

3. IF YES TO # 1, What Was Fee:
< Rps. 5,000
5,000 - 9,000
10,000 - 14,000
15,000 - 19,000
20,000+

14.0
47.0
25.5
9.5
4.0

27.6
34.1
21.6
12.3
4.5

18.0
29.2
16.9
14.9

17.4
43.1
24.4
10.5
4.6

4. Was This Fee Considered Expensive:
Expensive
Average
Cheap

15.3
55.1
29.6

13.7
57.1
29.2

10.9
55.0
34.1

14.5
55.6
29.8

1. Was A Removal Fee Charged:
Yes
No
Don't remember
2. At the Time of Insertion, informed About
Removal Fee:
Yes
No
Don't remember

7.

NORPLANT® Continuation Rates

NORPLANT® is recommended for use through five years. Table 12 below shows the
life table continuation rates for insertion cohort who continued with the method for one or
more years. It should be noted that the insertion cohorts from 1989 through 1991 have not
had the opportunity to continue as long as the earlier two insertion cohorts thus the data for
the later cohorts is censored.
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Life Table Cumulative Probabilities of Continuing with NORPLANT@

Table 12:

YEARS

PERCENT CONTINUING TO END OF PERIOD

_

NORPLANT* Insertion Cohorts

The data in Table 12 is graphically presented in Figure 2 below.

NORPLANT CONTINUATION RATES BY COHORT
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This Figure clearly shows the very high continuation rate for each NORPLANT®
insertion cohort from 1987 through 1991. The Figure also illustrates the point that almost all
NORPLANT® acceptors (over 90 percent) continue through the fourth year. Then, between
the end of the fourth year there is the beginning of a sharp drop in use from 90 percent to 66
percent. This drop continues and accelerates from 66 percent at the end of the fifth year to 10
percent at the end of the sixth year of use.
Once again, this data emphasizes the point that whatever difficulties women may face
in terms of finding a provider and paying for removal fees, at least for this sample of
NORPLANT® users, the overwhelming majority of each insertion cohort obtain a removal
between the end of the fifth and the end of the sixth year of use. Certainly by the end of the
seventh year there is not an apparent, large backlog of removal cases, although it should be
noted that not every user has had a removal.
8.

Pregnant While Using NORPLANT®

All respondents were asked whether they became pregnant while using the implants.
On the women who had an implant in place, 42 or 1.4 percent said they became pregnant.
About two-thirds of these (26 out of 42 pregnant) had their implants between 1987 and 1989.
Almost all of them live in a rural area and had the implants inserted during a safari camp.
Eight of the women thought they became pregnant slightly before the NORPLANT® insertion
while 34 out of the 42 said that they conceived after they had their implants inserted. It should
be emphasized that all of this data is based on client self reports. No independent verification
of pregnancy after NORPLANT® insertion was possible. The data do suggest, however, the
need for careful screening and careful counselling prior to NORPLANT® insertion in order to
be reasonably sure that the client is not pregnant.
Although all of the women who said they became pregnant eventually had
NORPLANT® removed, many of these women indicated that they experienced some
difficulty in obtaining a removal. For example, 21 percent (9 women) said they didn't get a
removal immediately upon request; 17 percent (7 women) said they had to wait for two or
more days; and 17 percent (7 women) said they had to make two or more requests for a
removal.
Out of 42 pregnant women, the majority of them (31 women) had a live birth. The
outcome of the 42 pregnancies is shown below:
#
#
#

Miscarriage, 7 percent (3 women);
Abortion, 2 percent (1 woman);
Still birth, 7 percent (3 women);
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#
#
#

Live birth, 74 percent (31 women);
Live birth but died later, 7 percent (3 women);
Currently pregnant, 2 percent (1 woman)
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V.

CONCLUSIONS

Several major conclusions can be drawn from the findings of this NORPLANT®
Assessment Study:
#

Most NORPLANT® users obtain a removal between the end of the fifth year and
the end of the sixth year of use. The data strongly suggest that there is not a large
backlog of removal cases, particularly after the sixth year of use.

#

Two thirds of removals are performed by nurse midwives. About 28 percent of
removals are performed in private facilities. About 23 percent of removals are
done in Safari camps. Together, these three findings probably account for a large
under reporting of removals. Midwives, at least in the past, were unlikely to
report removals because technically, they were not allowed to perform removals.
Private facilities usually don't report removal procedures to the BKKBN. The
reporting procedures at Safari camps is usually not as good as it might be at
health facilities. These areas of potential under reporting need to be further
checked.

#

Recent NORPLANT® insertion cohorts are less likely to have a second
NORPLANT® insertion immediately after removal of the first set compared with
earlier insertion cohorts, and more likely to switch to other family planning
methods. This trend should be monitored because it may affect future
NORPLANT® demand levels.

#

Only 16 percent of those who are over due for a removal use any other form of
backup contraception. The use of a backup contraceptive method for those
overdue for removal should be strongly encouraged.

#

Helping NORPLANT® clients develop mechanisms to remind themselves of the
removal date and emphasizing to Kader the need to remind clients of the removal
date may be effective ways to assure that clients do not delay a removal after five
years of use.
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#

About 91 percent of all women who have had a removal received the removal
immediately upon request. The remaining 9 percent often had to wait several
days and often had to make two or more requests before obtaining a removal.

#

Almost 70 percent of all women said they were not informed at the time of
NORPLANT® insertion that there would be a fee charged for removal.

#

Among those who have not had a removal, the cost of the removal is perceived as
a barrier.

#

"Good Service" and "Familiarity with Staff" are important reasons why some
women use private facilities as opposed to government facilities for removal.

#

Obtaining a removal immediately on request is associated with accepting a second
NORPLANT® insertion and with using other family planning methods. Not
obtaining a removal immediately on request is associated with discontinuation of
all family planning.

#

The cost of a removal is higher at private facilities than at Government facilities.
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